The vast majority of mothers experience pain throughout their bodies, according to a new survey.
Bayer HealthCare will buy birth-control product maker Conceptus for $1.1 billion, the companies said.
Prasco Labs has signed a deal with WellSpring Pharmaceutical Corp. to market an authorized generic version of a drug for a rare tumor disorder.
Drug maker Actavis has acquired rights to a treatment for an experimental bacterial vaginosis from Valeant Pharmaceuticals International for about $55 million, the drug makers said.
The Food and Drug Administration has approved a new treatment for a genetic disorder that affects about 500 people in the United States and 3,000 worldwide, the agency said Tuesday.
The Food and Drug Administration has approved a drug made by Genentech for a rare form of arthritis in children, the company said Tuesday.
The Food and Drug Administration has approved a drug that reverses the effects of anticoagulant drugs in patients who have suffered acute major bleeding, the agency said.
The Food and Drug Administration declined to approve two drugs for HIV made by Gilead Sciences for which the company was seeking approval for use as part of treatment regimens.
A proposal by Canadian drug maker Valeant Pharmaceuticals International to purchase generic drug maker Actavis has fallen through, according to published reports.
Medical products manufacturer Covidien's pharmaceutical division is expanding an initiative to collect unused and unwanted medications.